What is the CVR number of ORIFARM A/S?

ORIFARM A/S is registered with CVR / Virk under CVR 26058708.

What is the revenue of ORIFARM A/S?

ORIFARM A/S reported revenue of DKK 1,2B in 2025.

ORIFARM A/S employs 40 people as of the latest annual report.

Thomas Brandhof is the CEO of ORIFARM A/S, in role since 2019.

Hans Carl Bøgh-Sørensen chairs the board of ORIFARM A/S, in role since 2025.

ORIFARM A/S's registered address is Energivej 15.

A/SActiveAdvertising protection

CVR 26058708Energivej 15, 5260 Odense SWholesale of pharmaceutical and medical goods· NACE 4646Est. 2001 · 25 years old40 employees

Actively employed in the business

Name	Role	Member since
Current (4)
TB Thomas Brandhof Chief Executive Officer	Chief Executive Officer	2019
HS Henrik Steen Jensen Founder	Founder	2001
SE Steffen Ebdrup Founder	Founder	2001
EJ Erik Jensen Founder	Founder	2001
Former (2)
TS Tine Søndergaard Jensen Chief Executive Officer	Chief Executive Officer	2015 – 2019
JP Jens Peter Nielsen Chief Executive Officer	Chief Executive Officer	2014 – 2015

Non-executive oversight

Name	Role	Member since
Current (3)
HC Hans Carl Bøgh-Sørensen Chairman	Chairman	2025
MF Mads Fink Eriksen Board of Directors	Board of Directors	2025
NL Nicki Lund Kristensen Board of Directors	Board of Directors	2025
Former (10)
PM Per Munk Laustsen Board of Directors	Board of Directors	2003 – 2008
AC Anders Carl Norstrand Board of Directors	Board of Directors	2005 – 2012
ES Erik Sandberg Chairman	Chairman	2014 – 2025
AR Anna Rehman Linder Board of Directors	Board of Directors	2014 – 2015
OI Ole Ibsen Board of Directors	Board of Directors	2008 – 2012
BB Birgitte Bøgh-Sørensen Board of Directors	Board of Directors	2014 – 2026
HC Hans Christian Eberhard Groth Teisen Board of Directors	Board of Directors	2012 – 2014
NT Niels Thorborg Board of Directors	Board of Directors	2001 – 2003
JM John Morell Frellsen Board of Directors	Board of Directors	2003 – 2005
OM Ole Michael Friis Chairman	Chairman	2001 – 2003

As of last annual report

Shareholder	Type	Ownership	Votes	Since
ORIFARM PI A/S	Company	100%	100%	2003

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.